May 22, 2025
2024
Summary / Key Findings:
  • Results were reported from 8 sites across the United States
  • Geographical differences were observed for opioids, poly-drug use, NPS and xylazine
  • Temporal comparisons were possible for sites collecting samples in multiple quarters
  • Fentanyl overwhelming remains the most commonly detected opioid nationally
  • Numerous NPS were detected, including bromazolam, MDMB-4en-PINACA, nitazene analogues, 2F-2oxo-PCE, and more
DOWNLOAD THE REPORT